RANDALL KENNETH EDWARD enters TC BIOPHARM (HOLDINGS) PLC with 3.42M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 5/20/2022ACC: 0001929926-22-000001
10% Owner
Since Feb 2022
3.42M
Baseline shares
2% direct
79.61K
Direct ownership
1 position
5.31M
Derivative underlying
1 instrument
2
Security positions
3.34M indirect
Non-Derivative Holdings2
Ordinary Shares [ADS]
DirectShares owned79.61K
Ordinary Shares [ADS]
IndirectShares owned3.34M
Total
79.61K direct·3.34M indirect3.42M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares [ADS] | 79.61K | Direct |
| Ordinary Shares [ADS] | 3.34M | Indirect |
| Total | 3.42M | 79.61K direct·3.34M indirect |
Derivative Holdings1
Warrants
IndirectUnderlying security
Ordinary Shares
Underlying shares
5.31M
Shares owned
N/A
Exercise price
4.25
Expiration
—
Exercise window
—
Total
Underlying
5.31M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Indirect | Ordinary Shares | 4.25 | — | — | 5.31M | N/A |
| Total | 5.31M | 0.00 | ||||